相关实验视频
Updated: Jan 8, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.8K
癌症中的瘤细胞可塑性:信号通路和药物干预
Shangwei Sun1, Yunwei Sun2, Ling Lan3
1Department of Thoracic Surgery West China Hospital, Sichuan University Chengdu Sichuan China.
MedComm
|December 19, 2025
概括
细胞可塑性驱动癌症的进化,使得转移和耐治疗. 了解和准这种适应能力是开发新的癌症治疗方法的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 细胞可塑性,细胞表型的动态变化,是瘤进化和癌症进展的关键因素.
- 这种适应性有助于恶性特征,如转移,瘤进展和对治疗的耐药性.
- 目前的理解需要一个统一的框架来将可塑性驱动因素与癌症特征联系起来.
研究的目的:
- 审查和定位细胞可塑性作为将癌症驱动因素与临床结果联系起来的中心机制.
- 探索塑性如何促进瘤演变的关键阶段,包括瘤发生,转移和治疗耐药性.
- 总结控制癌症细胞适应性的内在和外在机制.
主要方法:
- 文献综述综合了关于癌症细胞可塑性的当前研究.
- 探索可塑性在瘤进化,转移 (表皮-介质细胞可塑性),治疗耐药性和癌症干细胞动态中的作用.
- 讨论内在/外在调节机制和临床应用.
主要成果:
- 细胞可塑性是一个统一的过程,它将内在因素 (基因组不稳定性,表观遗传学) 和外在因素 (瘤微环境) 与癌症特征联系起来.
- 塑性是癌症进展的关键阶段的基础,包括表皮-介质细胞塑性 (EMP) 驱动的转移和癌症干细胞 (CSC) 动态.
- 监测和向可塑性的临床进展,以及时空技术,提供了新的治疗策略.
结论:
- 细胞可塑性是癌症进化的核心机制,它将基本驱动因素与临床转化联系起来.
- 向可塑性为开发指导瘤进化的主动癌症疗法提供了一个有希望的途径.
- 未来的研究应该利用时空技术来应对监测和操纵癌症可塑性的挑战.
相关概念视频
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K

